229 related articles for article (PubMed ID: 35295097)
21. [Microphysiological system as a promising technology for drug assay].
Ishida S; Kanamori T
Nihon Yakurigaku Zasshi; 2019; 154(6):345-351. PubMed ID: 31787688
[TBL] [Abstract][Full Text] [Related]
22. The vascular niche in next generation microphysiological systems.
Ewald ML; Chen YH; Lee AP; Hughes CCW
Lab Chip; 2021 Sep; 21(17):3244-3262. PubMed ID: 34396383
[TBL] [Abstract][Full Text] [Related]
23. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
[TBL] [Abstract][Full Text] [Related]
24. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
[TBL] [Abstract][Full Text] [Related]
25. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
[TBL] [Abstract][Full Text] [Related]
26. Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).
Maass C; Stokes CL; Griffith LG; Cirit M
Integr Biol (Camb); 2017 Apr; 9(4):290-302. PubMed ID: 28267162
[TBL] [Abstract][Full Text] [Related]
27. Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS).
Ueno R; Kuninori M; Sumi T; Sadeghian RB; Takata Y; Iguchi A; Tsuda M; Yamashita F; Ichikawa K; Yokokawa R
Micromachines (Basel); 2023 Mar; 14(4):. PubMed ID: 37420994
[TBL] [Abstract][Full Text] [Related]
28. Cross-industrial applications of organotypic models.
Kopanska KS; Rimann M
ALTEX; 2022; 39(1):155-158. PubMed ID: 35034134
[TBL] [Abstract][Full Text] [Related]
29. Progress in developing microphysiological systems for biological product assessment.
Mansouri M; Lam J; Sung KE
Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal microphysiological systems.
Blutt SE; Broughman JR; Zou W; Zeng XL; Karandikar UC; In J; Zachos NC; Kovbasnjuk O; Donowitz M; Estes MK
Exp Biol Med (Maywood); 2017 Oct; 242(16):1633-1642. PubMed ID: 28534432
[TBL] [Abstract][Full Text] [Related]
31. Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery.
Bai J; Wang C
Front Pharmacol; 2020; 11():407. PubMed ID: 32317971
[TBL] [Abstract][Full Text] [Related]
32. Microphysiological systems as reliable drug discovery and evaluation tools: Evolution from innovation to maturity.
Moon HR; Surianarayanan N; Singh T; Han B
Biomicrofluidics; 2023 Dec; 17(6):061504. PubMed ID: 38162229
[TBL] [Abstract][Full Text] [Related]
33. Applications of the microphysiology systems database for experimental ADME-Tox and disease models.
Schurdak M; Vernetti L; Bergenthal L; Wolter QK; Shun TY; Karcher S; Taylor DL; Gough A
Lab Chip; 2020 Apr; 20(8):1472-1492. PubMed ID: 32211684
[TBL] [Abstract][Full Text] [Related]
34. Microphysiological Systems: A Pathologist's Perspective.
Sura R; Van Vleet T; Berridge BR
Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532
[TBL] [Abstract][Full Text] [Related]
35. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
[TBL] [Abstract][Full Text] [Related]
36. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
[TBL] [Abstract][Full Text] [Related]
37. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
Low LA; Tagle DA
Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
[TBL] [Abstract][Full Text] [Related]
38. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.
Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL
Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546
[TBL] [Abstract][Full Text] [Related]
39. Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism.
Lee DW; Lee SH; Choi N; Sung JH
Biotechnol Bioeng; 2019 Dec; 116(12):3433-3445. PubMed ID: 31429925
[TBL] [Abstract][Full Text] [Related]
40. The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.
Sutherland ML; Fabre KM; Tagle DA
Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):I1. PubMed ID: 24565163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
